欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/1292/001
药品名称Waysus
活性成分
    • Azelastine hypochloride 137.0 µg
剂型Nasal spray, suspension
上市许可持有人Adalvo Limited Malta Life Sciences Park Building 1, Level 4, Sir Temi Zammit Buildings, San Gwann Industrial Estate SGN 3000 MALTA
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Slovenia (SI)
许可日期2024/11/20
最近更新日期2024/11/20
药物ATC编码
    • R01AD58 fluticasone, combinations
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Hybrid application (Art 10.3 Dir 2001/83/EC)
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase